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Abstract
Objective: Post-operative pulmonary complications significantly affect patient survival rates, but there is still no conclusive
evidence regarding the effect of post-operative respiratory failure after liver transplantation on patient prognosis. This study
aimed to predict the risk factors for post-operative respiratory failure (PRF) after liver transplantation and the impact on
short-term survival rates.
Design: The retrospective observational cohort study was conducted in a twelve-bed adult surgical intensive care unit in
northern Taiwan. The medical records of 147 liver transplant patients were reviewed from September 2002 to July 2007.
Sixty-two experienced post-operative respiratory failure while the remaining 85 patients did not.
Measurements and Main Results: Gender, age, etiology, disease history, pre-operative ventilator use, molecular adsorbent
re-circulating system (MARS) use, source of organ transplantation, model for end-stage liver disease score (MELD) and Child-
Turcotte-Pugh score calculated immediately before surgery were assessed for the two groups. The length of the intensive
care unit stay, admission duration, and mortality within 30 days, 3 months, and 1 year were also evaluated. Using a logistic
regression model, post-operative respiratory failure correlated with diabetes mellitus prior to liver transplantation, pre-
operative impaired renal function, pre-operative ventilator use, pre-operative MARS use and deceased donor source of
organ transplantation (p,0.05). Once liver transplant patients developed PRF, their length of ICU stay and admission
duration were prolonged, significantly increasing their mortality and morbidity (p,0.001).
Conclusions: The predictive pre-operative risk factors significantly influenced the occurrence of post-operative respiratory
failure after liver transplantation.
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Introduction
Liver transplantation (LT) is currently the only definite
treatment for acute liver failure and chronic end-stage liver
diseases. Because of a shortage of liver donations, patients may
have to wait for a long time for a liver transplantation. When liver
transplantations are performed, the patients are already very sick.
These patients may also have a high incidence of common
respiratory disorders including atelectasis, pleural effusion and
poor compliance of the respiratory system due to edema of the
chest wall or high intra-abdominal pressure. All of these
respiratory disorders can affect the function of alveolar gas
exchange. Some patients may even need intubation and
ventilation.
Liver transplantation is an upper abdominal surgery which
involves an extensive operation field and a long operation time.
The surgical wound transects the abdominal oblique muscles and
rectus muscles which are usually associated with respiratory
movements [1]. Patients undergoing upper abdominal surgery are
prone to diaphragmatic dysfunction which results in a 50–60%
reduction in vital capacity and 30% reduction in functional
residual capacity [2,3]. In addition, the usage of anesthetics and
the inhibitory effect of wound pain on coughing and mucous
removal usually contribute to the development of post-operative
pulmonary complications. In the literature, 5–10% of patients with
general surgery develop post-operative pulmonary complications,
especially in the patients with abdominal surgery [4]. Glanemann
et al. [1,5] observed that 11% of liver transplantation patients
required ventilator assistance after transplantation and 36.1%
required re-intubation. Among the patients who developed
pulmonary complications and needed re-intubation, 44.6% of
the patients were intubated within 24 hours after liver transplan-
tation. All of these pulmonary complications contribute to a
significant reduction in short-term survival.
Post-operative respiratory failure (PRF) [6,7] is one of the most
common post-operative pulmonary complications and may result
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morbidity after liver transplantation have been investigated.
However, the impact of PRF on LT patients’ prognosis is still
unclear.
The objective of this study was to identify which pre-transplant
risk factors are likely to cause PRF.
Results
Patients
A total of 147 liver transplant patients, 113 males and 34
females, were included in this study. The average age of these
patients was 50.268.7 years. The most common indication for
liver transplantation was liver cirrhosis (76.2%), followed by
fulminate hepatic failure (14.3%) and hepatocellular carcinoma
(8.8%). There was no significant difference regarding total
ischemic time (41.6611.4 minutes vs. 39.0610.4 minutes,
p=0.40, including cold and warm ischemic time) and duration
of surgery (12.962.1 hours vs. 14.262.1 hours, p=0.97). The
demographic characteristics of the patients are shown in Table 1.
Pre-operative co-morbidities included diabetes mellitus in 15% of
patients, impaired renal function in 17.7%, and ventilator usage in
10.2%. Pre-operative pulmonary function tests showed restrictive
defects in 17.7% of the patients. According to the Taiwan Organ
Registry and Sharing Center, the model for end-stage liver disease
(MELD) score is divided into three categories, 10–18, 19–24, and
$ 25, which accounted for 35.4%, 28.6%, and 36.1% of the
patients, respectively.
Univariate analysis
Among the 147 patients, 62 (42.2%) patients developed PRF
and 85 (57.8%) did not (Table 2). Among the 62 patients with
PRF, 14 (22.6%) required ventilation to support gas exchange pre-
operatively, and 32 (51.6%) required re-intubation after operation.
Among the 85 patients without PRF, only 1 (1.2%) required pre-
operative ventilation to support gas exchange (p,0.001). There
was no difference in age or sex between the two groups. The
etiology of liver disease in both groups was different (p=0.020).
The PRF group had more patients with fulminant liver failure
than the non-PRF group. There was a significant difference in
MELD categories between these two groups (p=0.004). Thirty
(48.4%) PRF group patients had a MELD score $ 25 while only
23 (27.1%) of the non-PRF group patients had a MELD score $
25. The severity of diseases was higher in the PRF group than in
the non-PRF group.
Pre-operative pulmonary function tests showed 27.4% restric-
tive defects in the PRF group, which was higher than in the non-
PRF group (p=0.008). Pre-operative co-morbidities including
diabetes mellitus and renal function insufficiency were also higher
in the PRF group than in the non-PRF group. Moreover, more
patients in the PRF group than in the non-PRF group required
MARS while waiting for liver transplantation (p=0.009). For
operation type, patients in the PRF group had a higher rate of
deceased donor liver transplantation than patients in the non-PRF
group (p=0.004). All of the deceased donors were brain-dead
donors.
Multivariate analysis
To determine the independent factors between these two
groups, all significant factors in univariate analysis were further
analyzed by logistic regression. The results showed that the risk
factors for PRF were diabetes mellitus, impaired renal function,
pre-operative ventilator support, usage of MARS, and deceased
donor liver transplantation (Table 3).
Once PRF developed, significant differences in post-operative
prognosis were observed in both groups (Table 4). The length of
ICU stay and duration of hospitalization were both longer in the
PRF group than in the non-PRF group. Thirty-day, three-month,
and one-year mortality rates were higher in the PRF group than in
the non-PRF group. Kaplan-Meier survival curves showed that
the survival rate at one year was 43.5% for the patients with PRF
and 90.6% for the patients without PRF (p,0.001) (Fig. 1). A total
of 43 patients died during the one-year study period (Table 4). The
causes of death of 35 PRF patients included sepsis with multiorgan
failure (29 patients), rejection (2), gastrointestinal hemorrhage (2),
cardiac dysfunction (arrhythmia, 1), and pulmonary embolism (1).
All the deaths in non-PRF group were due to sepsis with
multiorgan failure (8 patients).
There were 15 (10.2%) patients who required ventilator support
before transplantation. According to the medical records, there
were no preoperative ventilator associated pneumonias in our
patient population.
Discussion
This retrospective study showed that pre-operative ventilator
support, diabetes mellitus, impaired renal function, and deceased
transplant recipients were all pre-operative risk factors for PRF.
Once PRF developed, the length of stay at the intensive care unit
and total duration of hospitalization both increased and caused a
significant impact on short-term mortality after liver transplanta-
tion. Liver transplantation, compared with heart and kidney
transplantations, are particularly prone to PRF and acute
Table 1. Demographic data of the study subjects.
Demographic (n=147) Mean± SD (range)/number(%)
Gender, Male/Female 113(76.9)/34(23.1)
Age 50.268.7(45)
Comorbidities
Diabetes Mellitus 22(15.0)
Heart disease 4(2.7)
Hypertension 7(4.8)
Renal insufficiency 26(17.7)
Ventilation required pre-transplantation 15(10.2)
Pulmonary function test, restrictive
defects
26(17.7)
MARS 11(7.5)
Child-Turcotte-Pugh score
B 30(20.4)
C 117(79.6)
MELD
10–18 52(35.4)
19–24 42(28.6)
§25 53(36.1)
Donor Group
Living donor liver transplantation 93(63.3)
Deceased donor liver transplantation 54(36.7)
Abbreviations: MARS, Molecular adsorbent recycling system; MELD, Model for
end-stage liver disease score.
doi:10.1371/journal.pone.0022689.t001
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risk of respiratory failure and acute lung injury is considerably
lower after heart and kidney transplantation than liver transplan-
tation’’. Only 4.4% heart transplantation patients require
tracheostomy for the development of prolong respiratory failure.
Similarly, perioperative respiratory failure was documented in 4%
recipients of kidney transplantation. Once PRF develops, both
patient prognosis and survival rate are affected [9]. Glanemann et
al. [5] reported that of 546 liver transplantation patients, 11%
needed ventilator support for more than 24 hours, and 14.8%
underwent extubation within 24 hours but required re-intubation
later on. The patients in need of re-intubation have significantly
reduced survival rates [1]. Arozullah et al. [7] adopted a
prospective cohort model to predict the multi-factorial risk index
for PRF after major noncardiac surgery. They discovered that
37% of liver transplant patients developed PRF and were unable
to undergo extubation, while 29% of the patients who developed
PRF required re-intubation. For those patients who were unable to
undergo extubation, the mortality rate increased to 23% within 30
days. For those patients who were re-intubated, the mortality rate
increased to as high as 31% within 30 days. Golfieri et al. [10] also
described that 4–16% of patients who developed pulmonary
complications after liver transplantation deteriorated into acute
respiratory distress syndrome with a mortality rate as high as 80–
100%. Clearly therefore, patients suffering from PRF after
transplantation have a higher incidence of short-term mortality.
Table 2. Pre-operative clinical parameters of the patients who underwent liver transplantation (n=147), by univariate analysis.
Parameter Postoperative respiratory failure No postoperative respiratory failure p value
(n=62) (n=85)
Mean ± SD/number(%) Mean± SD/number(%)
Age, years 50.268.5 50.268.9 .995
Gender, Male 47(75.8%) 66(77.6%) .794
Etiology .020
Liver cirrhosis 47(75.8%) 65(76.5%)
Hepatocellular carcinoma 2(3.2%) 12(14.1%)
Fulminate hepatic failure 13(21.0%) 8(9.4%)
Comorbidities
Diabetes Mellitus 14(22.6%) 8(9.4%) .027
Heart disease 2(3.2%) 2(2.4%) 1.000
Hypertension 5(8.1%) 2(2.4%) .133
Renal insufficiency 19(30.6%) 7(8.2%) ,.001
Ventilator required pre-transplantation 14(22.6%) 1(1.2%) ,.001
MARS 9(14.5%) 2(2.4%) .009
Pulmonary function test .008
Restrictive defects 17(27.4%) 9(10.6%)
Donor Group .004
Living donor liver transplantation 31(50.0%) 62(72.9%)
Deceased donor liver transplantation 31(50.0%) 23(27.1%)
MELD .004
10–18 13(21.0%) 39(45.9%)
19–24 19(30.6%) 23(27.1%)
§25 30(48.4%) 23(27.1%)
Child-Turcotte-Pugh score .054
Class B 8(12.9%) 22(25.9%)
Class C 54(87.1%) 63(74.1%)
Abbreviations: MARS, Molecular adsorbent recycling system; MELD, Model for end-stage liver disease score.
doi:10.1371/journal.pone.0022689.t002
Table 3. Pre-operative predictors of post-operative
respiratory failure by multivariate analysis.
Parameter p value Adjusted odds ratio (95% CI)
Diabetes mellitus .001 7.55(2.28, 25.02)
Mechanical ventilation
pre-transplantation
.002 38.85 (3.78, 398.96)
Renal insufficiency .003 5.93(1.82, 19.35)
Deceased donor .006 3.44(1.42, 8.38)
MARS .024 14.09(1.42, 139.69)
MELD .152 2.21(0.75, 6.50)
Restrictive defects .728 0.78(0.19, 3.11)
Etiology .081 0.51 (0.24, 1.09)
Abbreviations: MARS, Molecular adsorbent recycling system; MELD, Model for
end-stage liver disease score.
doi:10.1371/journal.pone.0022689.t003
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liver transplant recipients in poor clinical condition at the time of
orthotopic liver transplantation, undergoing complicated surgery,
or receiving liver grafts with severe preservation injury. Our work
provides a worthwhile scientific study on the field of risk factors for
post-operative respiratory failure after liver transplantation and
the impact on short-term survival rates. Postoperative respiratory
failure is one of the most common post-operative pulmonary
complications and may result in mortality [12]. Gonza ´lez et al. [12]
suggested that the development of acute respiratory failure after
liver transplantation is affected by the following factors: female sex,
Child-Pugh class, pulmonary edema, postoperative acute renal
failure, cerebral dysfunction, and respiratory infection. However,
only few studies have addressed the impact of pre-transplantation
risk factors on the post-operative respiratory failure after liver
transplantation. Besides, pre-transplantation risk factors that affect
mortality and morbidity after liver transplantation have been
investigated. For example, Preeti JR et al. [13] reported that
preexisting diabetes is associated with a significant post-orthotopic
liver transplantation morbidity and mortality. However, the
impact of post-operative respiratory failure on liver transplantation
patients’ prognosis is still unclear. Therefore, our paper will
provide comprehensive and potential information for clinical
physician to improve the critical care for these patients.
Multisystem organ failure (MSOF) is important for liver
transplantation patients. In our study, liver transplantation
patients were tightly monitored once they are on the waiting list.
Multisystem organ failure occurred before surgery is not suitable
for liver transplantation. Actually, in our previous study [14]
entitled ‘‘Scoring Short-Term Mortality After Liver Transplanta-
Figure 1. The survival rate for patients with or without PRF by Kaplan Meier analysis.
doi:10.1371/journal.pone.0022689.g001
Table 4. Pre-operative predictors of short-term morbidity and mortality rate.
Parameter Postoperative respiratory failure No postoperative respiratory failure p value
(n=62) (n=85)
Median (IQR)/number (%) Median (IQR)/number (%)
ICU stay, d 27 (6, 152) 9 (1, 65) ,.001
Hospital stay, d 51 (6, 231) 32 (5, 156) ,.001
Mortality (30-days) 23 (37.1) 1 (1.2) ,.001
Mortality (three-months) 28 (45.2) 1 (1.2) ,.001
Mortality (one-year) 35 (56.5) 8 (9.4) ,.001
Abbreviations: ICU stay, intensive care unit stay.
doi:10.1371/journal.pone.0022689.t004
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for measuring multiple organ failure for patients and found that
SOFA scores calculated before liver transplantation were statisti-
cally significant predictors of 3-month and 1-year posttransplant
mortality. However, only SOFA on post–liver transplant day 7
had the best discriminative power for predicting 3-month and 1-
year mortality after liver transplantation. Interestingly, in our
study, we found that the PRF on post-liver transplant day 2 was
associated with a higher SOFA score on post-liver transplant day
7, compared with those in patients without PRF (8.163.4 vs.
4.961.8, p,0.001). It suggested that PRF on post–liver transplant
day 2 is an earlier predictor for the outcome than the SOFA score
as described in the previous study.
There was a higher rate of post-operative respiratory failure in
our population. It might be a matter of local differences in
anesthetic and ICU management, or differences in patient or
donor graft characteristics compared to other reports. We had
reviewed the previous studies on early extubation in liver
transplant recipients and found that there are some discrepancies
in the patient’s enrollment. The exclusion criteria in the
literature on early extubation in transplant recipients included
acute hepatic failure, ventilator required pretransplantion [15]
and living donors [16]. However, in our study, we did not
exclude the patients mentioned above. In addition, given the
limited source of organ donors, the waiting time for prospective
liver transplantation is long, making it difficult to control the
disease severity. Concerning the donor group in our data, there
is 36.7% patients received deceased donors. Obviously, deceased
donors group had higher MELD score (25.668.4) compared
with living donors and deceased donor liver transplantation
belongs to the urgent surgery. While comparing the severity of
liver disease before surgery, patients with Child’s class C
occupied 79.6%, which was higher than that in previous study
[17,18]. Those are the reasons why there is a higher prevalence
of respiratory failure in our population. The outcomes differ
among institutions and dependent upon experience, resources
and the patient population. While the description of respiratory
failure in their patient population is of some interest, most
readers will reject the data if it is not similar to their own
experience. It is very apparent that there are a number of peer
reviewed publications with different outcomes. However, the one
thing that is applicable to all centers is the systematic study of
risk factors for each institution.
Impairment of renal function is an independent risk factor for
the development of post-operative pulmonary complications. In
this study, pre-operative impairment of renal function between the
PRF and non-PRF patients was significantly different. Multivar-
iate analysis also showed that impaired renal function was an
independent factor with an adjusted odds ratio of 5.93 (95% CI,
1.82–19.35; p=0.003). All the patients in our study with
preoperative renal insufficiency did not require preoperative
dialysis, as well as intraoperative dialysis or ultrafiltration.
Impaired renal function with an imbalanced pH value increases
the work of breathing and reduces pulmonary compliance. Once
respiratory failure occurs and mechanical ventilation is adopted,
the high intra-thoracic pressure will affect the systemic and renal
hemodynamics leading to a drop in cardiac output that will in turn
affect renal blood flow [19]. Nair et al. [8] showed that pre-
operative serum level of creatinine (.1.5 mg/dl) was an important
indicator for assessing post-operative ICU stay as well as short-
term survival rate [20,21,22]. These results imply that it is better to
perform liver transplantation before renal function becomes
impaired. In our study, we did not perform combined liver kidney
transplantation in our renal failure patients.
Diabetes mellitus patients are prone to have delayed wound
healing after major surgery and an increased risk of infection and
morbidity. The results in this study showed that patients suffering
from diabetes mellitus prior to surgery had a higher chance of
developing PRF after surgery. The hazard ratio for diabetes
mellitus was 7.55 (95% CI, 2.28–25.02; p=0.001). Immunosup-
pressive agents such as tacrolimus and steroids may influence the
metabolism of glucose. Impaired renal function and gastric
emptying may both interfere with blood levels of immunosup-
pressants and ultimately lead to poor blood glucose control and
infections. Preeti et al. [13] discovered that compared to non-
diabetic patients, diabetic patients had a significantly higher serum
creatinine level prior to liver transplantation and a higher
incidence of pulmonary complications after transplantation
(p=0.001).
The usage of MARS was a risk factor to develop post-operative
PRF. Eleven patients in the current study received MARS
combined with dialysis treatment. Of these 11 patients, 9
(81.8%) developed PRF, which was significantly higher than in
the patients who did not receive MARS (p=0.009). Using an
artificial liver/biological artificial liver as a support system to
extend the waiting time increases the opportunity of liver
transplantation for acute liver failure patients. Most toxins
produced by liver failure bind to albumin, and traditional
hemodialysis cannot effectively remove the toxicity for acute liver
failure patients. Non-biologic artificial liver support therapies,
MARS, combine a molecular adsorbent re-circulating system and
a dialysis system to remove water-soluble and protein-bound
toxins. The mortality rate within one week has been shown to be
100% and 63% for the control group and the MARS-treatment
group, respectively [23]. Although MARS treatment extends the
waiting time for liver transplantation and possibly improves the
survival rate for the patients with hepato-renal syndrome, the
usage of MARS is still a risk factor to develop PRF.
According to previous report, the criteria of MARS including
acute decompensation on chronic liver disease, acute liver failure,
primary graft dysfunction, liver failure post-liver surgery and
intractable pruritus in chronic cholestatic syndromes [24]. The
waiting time for prospective liver transplantation is long, making it
difficult to control the disease severity. In aid of extending the
waiting time, 11 patients (7%) in our study received MARS to
increase the opportunities of liver transplantation for acute
decompensation on chronic liver disease and acute liver failure
patients requiring intubation.
The patients were divided into three groups according to a
MELD score of 10–18, 19–24, and $ 25 in this study. Thirty
among 62 patients (48.4%) with PRF had a MELD score $ 25,
compared to 23/85 (27.1%) patients in the non-PRF group.
Among all 53 patients with a MELD score $ 25, the incidence of
PRF was 56.6% (30/53), compared to 45.2% (19/42) for the
patients with a MELD score between 19 to 24 and 25% (13/52)
for the patients with a MELD score between 10 to 18. These
results implied that the patients with a high MELD score had a
higher incidence of PRF. Saab et al. [25] reported that the one-
year survival rate was significantly different when the patients were
divided into MELD scores , 24 and . 24. Previous studies have
noted that MELD score could more accurately predict ventilator
usage for gas exchange support in liver pre-transplantation than
the CTP score, however, it could not be used to predict short-term
survival rate [26,27,28,29]. In this study, MELD score was not an
independent factor to predict PRF, however, the patients with
high MELD scores may have had a higher rate of comorbidities.
In previous study [30], patients were initially stratified into 7
groups based on the MELD score of ,10, 11–15, 16–20, 21–25,
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compared among the groups. Groups with similar results were
merged to develop 3 larger categories as defined by pretransplan-
tation MELD of ,15 (low risk), 16–25 (medium risk), and .25
(high risk). It is consistent with our stratification for the
pretransplant MELD scores. Based on this MELD scoring system,
patients are equally distributed in the three categories and are
suitable for analysis. In our study, it did show that a MELD score
of 25–40 is significantly associated with a higher rate of PRF,
compared with those in other groups.
Feng et al. [31] suggested that the donor risk index (DRI),
calculated by eight-parameter formula, was an important
predictor of graft failure. In another cohort study, Maluf et al.
[32] found that a DRI of more than or equal to 1.7 is a cutoff
value in defining an extended criteria for donor graft. In our study,
the DRI between non-PRF and PRF patients was not significantly
different (1.42360.210 and 1.49960.342; p=0. 578), both were
less than 1.7, suggesting that DRI may not a predictor of post-
operative respiratory failure in our patient population.
Intraoperative care is also an important issue. Actually, we
found that there was significant difference in the perioperative
blood loss between non-PRF and PRF patients (395463921 ml
and 665766566 ml; p=0.013). More patients in non-PRF group
completed the surgical procedure without the need for blood
transfusion compared with the PRF group. We believe that
perioperative care of transplant recipients should be an important
predictor of outcome. However, our present study highlights the
role of pre-operative risk factors. It needs further study to
investigate the perioperative risk factors associated with PRF.
Previous papers have found encephalopathy, massive transfu-
sion requirements, primary graft failure, cardiac failure, multior-
gan transplant, and retransplantation were all contraindications to
early (,24 h) extubation after liver transplantation. However, in
our study population, there were no patients who were primary
graft failure, cardiac failure, multiorgan transplant, and retrans-
plantation. Similarly, no patients had required massive transfusion
before transplantation. In our study, encephalopathy was a
fluctuated factor that is difficult to evaluate from the medical
record. It needs further study to investigate the indicator.
In our study, 93 (63.3%) patients received living donor liver
transplantation (Table 1). Previous studies [16] have suggested
living donation is a contraindication to early extubation. However,
in our data, we found that living donor liver transplantation had a
lower rate (31/93, 33.3%) of PRF, in contrast with deceased donor
liver transplantation (31/54, 57.4%)(Table 2). Our finding is
interesting and provides a potential therapeutic direction for
clinical practice.
There were significant differences in ICU stay after surgery,
hospital stay, 30-day mortality, three-month mortality, and one-
year mortality between patients with or without PRF. Kaplan-
Meier survival analysis showed that the prognosis for the patients
with or without PRF was also significantly different.
Although transplantation is effective, the possibility of trans-
plantation depends on the availability of a liver donor. Therefore,
predictors of mortality risk and models for the short term prognosis
of end-stage liver disease are needed to help clinicians and
policymakers predict the outcomes of liver transplantation. In our
previous study [14], we found that among 4 evaluated scoring
systems: (1) The Sequential Organ Failure Assessment (SOFA)
score, (2) Child-Pugh points, (3) Model for End-Stage Liver
Disease score, and RIFLE (risk of renal dysfunction, injury to the
kidney, failure of the kidney, loss of kidney function, and end-stage
kidney disease) criteria, only the SOFA scores calculated before
liver transplantation were statistically significant predictors of 3-
month and 1-year posttransplant mortality. SOFA on post–liver
transplant day 7 had the best discriminative power for predicting
3-month and 1-year mortality after liver transplantation. More-
over, Preoperative hyponatremia was also a significant risk for
postoperative complications and short-term graft loss [33]. The
addition of sodium concentration to MELD score might therefore
be an effective predictor for post-transplant short-term mortality in
deceased donor liver transplantation. Older patient and donor age
[34], male sex of recipient, retransplantation, and high pre-
transplant MELD score are associated with poor post-transplant
outcome [30]. Our study provided a new concept that post-
operative respiratory failure is a key factor in liver transplant that
carries prognostic impact in the recipients.
After liver transplantation, patients need to receive regular
immunosuppressive treatment, compared with other surgical
patients. It is supposed that patients would have a high infection
opportunity. However, only few studies have addressed the impact
of infection on the short-term mortality after liver transplantation.
Better predictive models are needed to assess the infection
associated short-term mortality.
Conclusion
In conclusion, this study identified several pre-operative risk
factors for PRF, which lead to a prolonged ICU and hospital stay
and admission duration and affected morbidities and mortality.
We recommend that ventilated patients should be weaned, and
impaired renal function and coagulation function be well
controlled prior to liver transplantation in order to reduce PRF
and thereby improve outcomes.
Materials and Methods
Patients
The study design was a retrospective review of patient records
with approval of Institutional Review Board (IRB), Chang Gung
Medical Foundation (IRB no.: 97-0567B). Methodology and
patient confidentiality were approved by our IRB. The IRB
confirmed that this study constituted an audit, which did not
require patient consents to this retrospective study. From
September 2002 to July 2007, the medical records of 153 patients
who had liver transplantations in Chang-Gung Memorial Hospital
were reviewed. Six patients were excluded due to incomplete data
collection. Therefore, 147 patients were included in this study.
Definition of post-operative respiratory failure
In our ICU, a weaning protocol was followed to wean the
ventilator after transplantation surgery. Briefly, weaning was
started after reversal of neuromuscular function, under adequate
of cardiovascular, respiratory and metabolic function, and the
weaning criteria were fulfilled: rapid shallow breathing index or
respiratory rate/tidal volume ratio #105 breaths/min/L (tidal
volume.5 ml/Kg, frequency less than 30 breaths/min; maximum
inspiratory pressure or negative inspiratory force less than -
30 cmH2O). The arterial blood gas analysis was within normal
limit under FiO2#0.4 and PaO2/FiO2 ratio.350. When the
patient was stable and could maintain spontaneous breathing for
30–60 minutes, the surgeon and respiratory therapist determined
whether an extubation should be performed in accordance with
the above weaning criteria.
Post-operative respiratory failure (PRF) [6,7] was defined as
patients requiring ventilator support for more than 48 hours or
patients having re-intubation. All 147 patients were divided into
two groups: PRF patients, who developed post-operative respira-
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operative respiratory failure.
Anesthetic regimen and early enteral feeding protocol
Short-acting anesthetic drugs were used as anesthetic regimen
for our patients, including midazolam, fentanyl, and rocuronium
that were administered on a dose per weight basis at induction.
Anesthesia was maintained with an oxygen-air-isoflurane mixture
and intermittent doses of cis-atracurium were given for continuing
muscle relaxation. A standardized surgical technique performed
by the same surgical team was used for all patients. The specific
time for inferior vena cava clamping, portal venous reperfusion,
and hepatic artery reperfusion was protocol-controlled to within
10 to 15 minutes. All patients were transferred to the ICU for post-
transplantation care, including early enteral feeding protocol.
Once patients exhausted, enteral feeding was started.
Data collection
The data collected included patient profiles, etiology of diseases,
history of systemic diseases (diabetes mellitus, hypertension, heart
disease, or rental insufficiency), the definition of renal insufficiency
as serum creatinine more than 1.5 mg/dL, or creatinine clearance
(CCr) less than 70 mL/min following a previous report [8], pre-
operative ventilator usage, model for end-stage liver disease score
(MELD), Child-Turcotte-Push (CTP) Classification, pre-operative
usage of molecular adsorbent re-circulating system (MARS), pre-
operative pulmonary function tests (most recent pulmonary
function (#3 months) on file as relevant reference for liver
transplantation), pre-operative laboratory data, length of intensive
care unit (ICU) stay, and duration of hospitalization. The post-
operative mortality within 30 days, three months, and one year
were also collected.
Statistical analysis
Data were analyzed using the statistical software package SPSS
(Version 15 SPSS, Chicago, IL). Data were shown as mean 6 SD,
median with range, or percentages. The univariate relationship
between each variable and PRF was tested using Pearson’s chi-
square or Fisher’s exact tests. All significant variables in univariate
analysis were analyzed by multiple regression logistic models.
Overall patient survival was estimated using the Kaplan-Meier
survival analysis. A p value , 0.05 was considered statistically
significant.
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